Novel treatment for acute organic cerebral syndromes (strokes)

Details Novel treatment for acute organic cerebral syndromes (strokes) Novel treatment for acute organic cerebral syndromes (strokes)

1976-12-08

1979-05-15

Waddell, Frederick E.

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Bacterium or component thereof or substance produced by said...

A61K 31495

Patent

active

041548329

ABSTRACT:
S-Triazolo-[4,3-a]-pyridine derivatives and their nontoxic salts have been found to have pharmaceutical activity in the treatment of individuals suffering from the acute phases of the organic cerebral syndrome (stroke).

REFERENCES:
patent: 3381009 (1968-04-01), Palazzo et al.
The Merck Manual, (1972), 12th Ed., pp. 1320-1329.
Manual of Medical Therapeutics, 19th Ed., Smith, Little, Brown and Company, Boston, pp. 355-356.
Stroke, vol. 2, Jul.-Aug., 1971, pp. 327 and 341.
Neurology, vol. 22, Apr., 1972, pp. 377-383.
Trazodone, Med. Probl., Pharmacopsychiat., vol. 9, Biochemistry Session, Garattini, pp. 29-46, 1974.
Current Therapy, (1975), pp. 638-664, W. B. Saunders Co., Phila.
Goodman et al.--(The Pharm. Basis of Ther.)--5th Ed., pp. 721, 722, 740 and 741.

Affiliated with

Also associated with

Rating

Novel treatment for acute organic cerebral syndromes (strokes) does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Novel treatment for acute organic cerebral syndromes (strokes), we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel treatment for acute organic cerebral syndromes (strokes) will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1097301